Regardless of clinical stage of breast cancer at time of original presentation. Evaluation for local recurrence in patient with history of mastectomy. Minimal residual breast tissue remains after all forms of mastectomy [199]. Although locoregional recurrence is typically detected clinically, some are incidentally detected by imaging, during the screening examination of the native contralateral breast. For these reasons, ASCO recommends frequent clinical surveillance with physical examination and history every 3 to 12 months for the first 5 years after mastectomy, followed by annual clinical breast examination in subsequent years [173]. Digital Breast Tomosynthesis Diagnostic There is no evidence to support the use of DBT to evaluate for recurrence after mastectomy in an asymptomatic patient. Digital Breast Tomosynthesis Screening There is no evidence to support the use of screening DBT to evaluate for recurrence after mastectomy. Imaging of Invasive Breast Cancer FDG-PET/CT Skull Base to Mid-Thigh In asymptomatic patients with a history of breast cancer who received treatment for curative intent, there is no role for imaging to screen for locoregional recurrences with FDG-PET/CT skull base to mid-thigh. ASCO, NCCN, and ESMO all recommend against the routine use of imaging to screen for distant disease recurrence [172,173,200]. Mammography Diagnostic There is no evidence to support the use of diagnostic mammography to evaluate for recurrence after mastectomy in asymptomatic women. Mammography Screening There is no evidence to support the use of screening mammography to evaluate for recurrence after mastectomy. Mammography With IV Contrast There is no evidence to support the use of CEM to evaluate for recurrence after mastectomy in asymptomatic women. MRI Breast Without and With IV Contrast High-risk women with mastectomies may benefit from MRI surveillance of their remaining breast.
Imaging of Invasive Breast Cancer. Regardless of clinical stage of breast cancer at time of original presentation. Evaluation for local recurrence in patient with history of mastectomy. Minimal residual breast tissue remains after all forms of mastectomy [199]. Although locoregional recurrence is typically detected clinically, some are incidentally detected by imaging, during the screening examination of the native contralateral breast. For these reasons, ASCO recommends frequent clinical surveillance with physical examination and history every 3 to 12 months for the first 5 years after mastectomy, followed by annual clinical breast examination in subsequent years [173]. Digital Breast Tomosynthesis Diagnostic There is no evidence to support the use of DBT to evaluate for recurrence after mastectomy in an asymptomatic patient. Digital Breast Tomosynthesis Screening There is no evidence to support the use of screening DBT to evaluate for recurrence after mastectomy. Imaging of Invasive Breast Cancer FDG-PET/CT Skull Base to Mid-Thigh In asymptomatic patients with a history of breast cancer who received treatment for curative intent, there is no role for imaging to screen for locoregional recurrences with FDG-PET/CT skull base to mid-thigh. ASCO, NCCN, and ESMO all recommend against the routine use of imaging to screen for distant disease recurrence [172,173,200]. Mammography Diagnostic There is no evidence to support the use of diagnostic mammography to evaluate for recurrence after mastectomy in asymptomatic women. Mammography Screening There is no evidence to support the use of screening mammography to evaluate for recurrence after mastectomy. Mammography With IV Contrast There is no evidence to support the use of CEM to evaluate for recurrence after mastectomy in asymptomatic women. MRI Breast Without and With IV Contrast High-risk women with mastectomies may benefit from MRI surveillance of their remaining breast.